以上内容来自Benzinga Earnings专栏,原文如下:
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.02) by 150 percent. This is a 105.26 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $59.87 million which missed the analyst consensus estimate of $59.94 million by 0.13 percent. This is a 32.76 percent increase over sales of $45.09 million the same period last year.
精彩评论